Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028012 · ClinicalTrials.gov registry record · Phase 4
TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone
A Phase 4 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03028012 is a Phase 4 study that was terminated before completion, run by University of Utah. The registered enrollment target is 10 participants.
The verdict
NCT03028012, a Phase 4 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
Hypothesis The main hypothesis of this study is that anti-inflammatory medications (ketorolac or dexamethasone) will provide longer-lasting and greater pain relief than just lidocaine in trigger point injections where a local twitch response is evoked at the time of the injection. Purpose/Specific Aims The primary objective of this study is to compare the efficacy of three substances used in TPIs with a LTR identified at the time of the injection: a CS (dexamethasone), a NSAID (ketorolac), or only a local anesthetic (lidocaine).
Interventions
- DRUG Ketorolac
- DRUG Dexamethasone
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2019-05-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028012
The ClinicalTrials.gov registry entry for NCT03028012 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketorolac is the first listed.
NCT03028012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03028012 about?
NCT03028012 is a clinical study titled "TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone". Hypothesis The main hypothesis of this study is that anti-inflammatory medications (ketorolac or dexamethasone) will provide longer-lasting and greater pain relief than just lidocaine in trigger point injections where a local twitch response is evoked at the time of the injection. Purpose/Specific...
What is the current status of trial NCT03028012?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2017-05-02. Estimated completion is 2019-05-01.
What interventions are being tested in trial NCT03028012?
The interventions under investigation include: Ketorolac (DRUG), Dexamethasone (DRUG), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT03028012?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.